skip to main content

ProfessionalsMohammed A. Alvi

Mohammed A. Alvi
Partner

Tel: +1-310-982-4366
Fax: +1-310-496-0426
malvi@paulweiss.com

+1-310-982-4366
Los Angeles

2029 Century Park East, Suite 2000
Los Angeles, California 90067-3006
Fax: +1-310-496-0426

+ vCard ADD TO CONTACTS
Education 
Bar Admissions 
Education 
Bar Admissions 

Mohammed Alvi is a Finance partner in Paul, Weiss’s Los Angeles office where he represents private equity sponsors, private and public companies, direct lenders and underwriters in a variety of debt financing transactions.

Mohammed advises clients across all sectors, with a particular focus on technology, software, life sciences, healthcare, renewable energy, manufacturing and financial services. He has expertise in a broad array of debt financing transactions, including acquisition financings, recapitalizations, restructurings, and refinancings. Mohammed also has extensive experience in cross-border transactions, secured and unsecured credit facilities, high-yield bonds, and equity-linked debt offerings.

EXPERIENCE

Mohammed’s representative experience includes:

  • TA Associates in connection with financings for Backstage and Towne Park
  • Charlesbank in connection with financings for MB2 Dental, PakEnergy and Sightpath Medical
  • Great Hill Partners in connection with the acquisition financing and dividend recapitalization for One, Inc. Software Corporation
  • Accel-KKR in connection with the acquisition financing and subeqeunt refinancing for Recurly
  • Cano Health in connection with multiple financings arranged by Credit Suisse and JPMorgan, a secured term loan financing provided by Diameter Capital Partners and Rubicon Founders and a Rule 144A/Reg S high-yield bond offering
  • Collegium Pharmaceutical in connection with the acquisition financing for Ironshore Therapeutics
  • Fibrogen, Inc. in connection with a term loan financing and a royalty financing
  • Allurion Technologies in connection with a revenue interest financing, a secured term loan financing and a secured convertible note financing
  • TScan Therapeutics in connection with a secured convertible term loan financing
  • Moderna in connection with various debt financing matters
  • AXA Equitable in connection with multiple term loan, revolving credit and letter of credit facilities
  • Rite Aid in connection with the proposed sale to Walgreens Boots Alliance and the proposed merger with Albertsons
  • Jane Street in connection with multiple senior secured term loan financings
  • Citadel Securities in connection with a senior secured term loan financing
  • PennyMac in connection with multiple Rule 144A/Reg S high-yield bond offerings
  • Plug Power in connection with a proposed Rule 144A/Reg S high-yield bond offering
  • TPI Composites in connection with a secured term loan financing
  • Toast in connection with a convertible note financing and secured revolving credit facility
  • Enfusion in connection with a secured revolving credit facility
  • Hyperice in connection with multiple secured term loan and asset-backed loan financings
  • The Boston Celtics in connection with the entry into NBA league-wide credit facilities and refinancing of multiple series of privately-placed notes
  • AquaVenture in connection with the acquisition of the company by Culligan
  • Credit Suisse, as arranger, on multiple syndicated credit facilities for portfolio companies of New Mountain Capital
  • Jefferies Finance, as arranger, on syndicated credit facilities for Avantor
  • Braidwell, as lender, on secured term loan financings for Nevro and OrthoPediatrics
  • Piney Lake, as lender, on secured term loan financings and restructurings for SMI and Precision Technology

© 2024 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy